ArticleTranslational lung cancer research2025

A study protocol of a single-arm, prospective, open-label, non-controlled, phase II study of neoadjuvant BL-B01D1 combined with aumolertinib in resectable stage II-IIIB non-small cell lung cancer patients with

Yue Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.